Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramDirector, President and CEOCIK 0002001162
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Pfeiffenberger BrentDirector, President and CEO |  IPSCCentury Therapeutics, Inc.Tax withholding | F | $27K 13.8K sh | Sep 15, 2026 traded Sep 11, 2026 | |
Pfeiffenberger BrentDirector, President and CEO |
| IPSCCentury Therapeutics, Inc. Tax withholding |
| F |
| $977 463 sh |
| Sep 9, 2026 traded Sep 4, 2026 |
| 8 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $60K 31.2K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $31K 13.8K sh | Jun 15, 2026 traded Jun 11, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $986 463 sh | Jun 9, 2026 traded Jun 5, 2026 |
| 8 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $73K 31.2K sh | May 19, 2026 traded May 15, 2026 |
| 8 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $151K 55.4K sh | Mar 13, 2026 traded Mar 11, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $1,185 463 sh | Mar 10, 2026 traded Mar 6, 2026 |
| 9 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Grant or award | A | — 475.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Grant or award | A | — 945.0K sh | Feb 4, 2026 traded Feb 2, 2026 |
| 30 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market purchase | BUY | $30K 52.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 5 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Tax withholding | F | $244 463 sh | Dec 12, 2025 traded Dec 10, 2025 |
| 36 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market purchase | BUY | $17K 35.0K sh | Nov 20, 2025 traded Nov 19, 2025 |
| 31 | Pfeiffenberger BrentDirector, President and CEO | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $15K 32.5K sh | Nov 19, 2025 traded Nov 17, 2025 |